ENDRA Life Sciences Inc. Common Stock (NDRA) is a publicly traded Healthcare sector company. As of May 21, 2026, NDRA trades at $5.55 with a market cap of $6.71M and a P/E ratio of -0.63. NDRA moved +0.00% today. Year to date, NDRA is +22.52%; over the trailing twelve months it is +79.32%. Its 52-week range spans $2.90 to $22.68. Analyst consensus is buy with an average price target of $27.00. Rallies surfaces NDRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ENDRA Life Sciences Inc. Common Stock (NDRA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NDRA moved +0.00% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $5.55 |
| Market Cap | $6.71M |
| P/E Ratio | -0.63 |
| EPS | $-8.93 |
| Dividend Yield | 0.00% |
| 52-Week High | $22.68 |
| 52-Week Low | $2.90 |
| Volume | 16 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-7.03M |
| Gross Margin | 0.00% |
1 analysts cover NDRA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $27.00.